Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TRANSITION THERAPEUTICS INC. T.TTH

"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."


TSX:TTH - Post by User

Comment by deninsaskon Apr 15, 2007 1:25pm
317 Views
Post# 12610933

RE: KodaChrome Clear...........Patents

RE: KodaChrome Clear...........Patents Thanks for the clarification Polak.....it's nice to have someone posting Facts as they relate to Transition and The Boys efforts to increase shareholder value and increase awareness of the Co. I think they're doing a good job even though I've complained a lot in the past about lack of announcements regarding the start of the various trials and updates on enrollment and the like........ It is now more than Crystal Clear the approach now being taken for Securing the Patents. Anyone not on the same page should really read Dr. Andre Uddins Presentation Entitled "Intellectual Property" "What do Investors look for" In it he explains all the different Patents necessary to bring a drug to commercialization and at what steps in the regulatory process the patents are applied for. That and a lot of other goodies and a couple of Case Studies to boot. Dr. Andre Uddins Key Rules for Patenting.(from his biotech seminar at the MaRS last year) 1--Avoid Early Public Disclosure. File first then disclose. 2--Do Not publish Interim Results. 3--Research the market and technical Novelty of an invention before Patent Filing. 4--If you can not protect the Patent from Infringement, don't file. 5--File in the US FIRST.
Bullboard Posts